Compound Profile: Ultima-Adiptode (FTTP)
Ultima-Adiptode (FTTP) 2mg is a specialized adiponectin receptor targeting compound developed by Ultima Peptides for advanced metabolic research applications. This research chemical belongs to the class of adiponectin receptor modulators, designed to investigate the complex signaling pathways involved in glucose homeostasis and lipid metabolism. Researchers at Stroid UK Shop can study this compound’s interactions with AdipoR1 and AdipoR2 receptors in controlled laboratory environments. The 2mg formulation provides precise dosing capabilities for experimental protocols examining adiponectin pathway activation and downstream metabolic effects in cellular models.
Laboratory Applications
Research scientists utilize Ultima-Adiptode to examine adiponectin signaling mechanisms in various experimental contexts. Studies focus on investigating AMPK pathway activation, fatty acid oxidation processes, and glucose uptake mechanisms in isolated cell cultures. The compound enables researchers to evaluate metabolic flux changes and mitochondrial biogenesis responses under controlled conditions. Comparative studies with other peptides demonstrate unique receptor binding characteristics and tissue-specific responses. Laboratory protocols frequently incorporate this compound alongside established metabolic modulators to study synergistic pathway interactions and cellular energy balance mechanisms.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Content | 2mg per vial |
| Manufacturer | Ultima Peptides |
| Formulation | Lyophilized powder |
| Storage Requirements | -20°C (lyophilized), 2-8°C (reconstituted) |
| Stability | 36 months sealed, 30 days reconstituted |
| Solubility | Water soluble |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
Research facilities studying metabolic pathways often combine this compound with investigations into SARMs to examine comprehensive anabolic-metabolic interactions in experimental models.
Regulatory Compliance
Ultima-Adiptode (FTTP) 2mg is supplied exclusively for in-vitro research purposes and is not intended for human consumption, therapeutic use, or clinical applications. This research chemical must be handled by qualified laboratory personnel in appropriate research facilities following institutional safety protocols. Researchers should maintain proper documentation of experimental procedures and storage conditions. All studies involving this compound must comply with relevant research institution guidelines and local regulations governing research chemical use.

